Alnylam Pharmaceuticals, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 121.7M |
| FY2023 | 124.9M |
| FY2024 | 127.7M |
| FY2025 | 134.7M |
| FY2026 | 132.6M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 121.7M |
| FY2023 | 124.9M |
| FY2024 | 127.7M |
| FY2025 | 134.7M |
| FY2026 | 132.6M |